Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell Crimson Tide (TIDE) by Steve Moore in ShareProphets
- Avoid Kainos Group (KNOS) by Steve Moore in ShareProphets
- Buy Chemring Group (CHG) by Jefferies
- Buy British American Tobacco (BATS) by Bank of America
- Avoid Cambridge Nutritional Science (CNSL) by Steve Moore in ShareProphets
- Buy Vesuvius (VSVS) by Jefferies
- Buy Water Intelligence (WATR) by Hot Stock Rockets in ShareProphets
- Hold Hilton Food Group (HFG) by Peel Hunt
- Buy M&G (MNG) by Simon Watkins in The Motley Fool
- Buy Linde (0M2B) by UBS
- Sell Croda International (CRDA) by Goldman Sachs
- Sell Ashmore Group (ASHM) by Deutsche Bank
- Outperform 3i Infrastructure (3IN) by RBC Capital
- Hold Tullow Oil (TLW) by Shore Capital
- Buy Applied Nutrition (APN) by Deutsche Bank
- Buy Pennon Group (PNN) by Deutsche Bank
- Buy United Utilities Group (UU.) by Deutsche Bank
- Buy Currys (CURY) by Deutsche Bank
- Buy Rightmove (RMV) by Deutsche Bank
- Hold Severn Trent (SVT) by Deutsche Bank
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,238 open tips for AstraZeneca (AZN)
| Latest Bid : 13,484.00p | Latest Ask : 13,488.00p |
| High Today : 13,494.00p | Low Today : 13,284.00p |
| This Years High : 13,494.00p | This Years Low : 9,667.00p |
| Volume : 783,318 | MKT Cap : £208723M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | DZ Bank | Premium Only | 2025-11-10 13:02:00 10/11/2025 | 3.09% |
| Buy | Goldman Sachs | Premium Only | 2025-11-07 06:21:00 07/11/2025 | 5.30% |
| Buy | Shore Capital | Premium Only | 2025-11-06 18:00:00 06/11/2025 | 5.30% |
| Buy | Jefferies | Premium Only | 2025-10-27 07:08:00 27/10/2025 | 7.47% |
| Buy | Berenberg | Premium Only | 2025-10-22 05:26:00 22/10/2025 | 8.61% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 13,484.00p | Latest Ask : 13,488.00p |
| High Today : 13,494.00p | Low Today : 13,284.00p |
| This Years High : 13,494.00p | This Years Low : 9,667.00p |
| Volume : 783,318 | MKT Cap : £208723M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | DZ Bank | Premium Only | 2025-11-10 13:02:00 10/11/2025 | 3.09% |
| Buy | Goldman Sachs | Premium Only | 2025-11-07 06:21:00 07/11/2025 | 5.30% |
| Buy | Shore Capital | Premium Only | 2025-11-06 18:00:00 06/11/2025 | 5.30% |
| Buy | Jefferies | Premium Only | 2025-10-27 07:08:00 27/10/2025 | 7.47% |
| Buy | Berenberg | Premium Only | 2025-10-22 05:26:00 22/10/2025 | 8.61% |